Pitt Shield

Focused-ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate.

Authors: O'Reilly MA, Waspe AC, Ganguly M, Hynynen K

Blood-brain barrier disruption (BBBD) shows promise for drug delivery in the brain; however, optimal parameters for disruption have yet to be firmly established. Previous work has shown that BBBD can be achieved using bursts comprised of microsecond-length pulses at 50% duty cycle to eliminate standing waves and variability. The capabilities and limitations of this sort of pulse sequence comprising short bursts were examined. Ultrasound-induced BBBD was performed in 28 rats using Definity contrast agent. The spacing between 3-μs pulses at 1.18 MHz was either 6 μs, 60 μs, 300 μs or 600 μs during a 10-ms pulse, or 1 s for a single-pulse burst. The rate of infusion of the microbubbles was also examined, as well as the burst pulse repetition frequency (PRF) under infusion conditions. A semi-log relationship between enhancement mean and the number of cycles in a burst was discovered, with a one-pulse burst (i.e., a 3-μs burst at 1 Hz) still capable of disrupting the BBB. No increased efficacy or safety benefit over bursts containing more cycles was found, however. Microbubble infusions showed no improvement in T1w enhancement, but did improve consistency. Increased burst PRF combined with infusion improved T1w enhancement but without statistical significance, whereas a decrease in burst PRF showed a statistically significant decrease in enhancement.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To evaluate how microsecond-length pulsed ultrasound burst parameters (pulse spacing, number of cycles, burst PRF) and microbubble infusion affect ultrasound-induced blood-brain barrier disruption in rats.
Animal model / Human subject Rat (Rattus norvegicus); strain None; age None; sex None
Disease model healthy (normal rats, blood-brain barrier disruption model)
Cargo name and characteristics Focused ultrasound (ultrasound pulses) — 1.18 MHz carrier frequency; individual pulse duration 3 μs; pulses delivered in short bursts (10 ms burst duration for multi‑pulse conditions) with 50% duty cycle within bursts; inter‑pulse spacings tested within bursts: 6 μs, 60 μs, 300 μs, 600 μs; also tested single‑pulse bursts with 1 s spacing (1 Hz); burst PRF varied (including increased and decreased PRF conditions); applied transcranially in rats for blood–brain barrier disruption.
Route of administration Intravenous (microbubble infusion of Definity)

Outcomes and Safety

Summary of Outcomes Ultrasound bursts as short as a single 3 μs pulse at 1 Hz can disrupt the blood–brain barrier, with enhancement scaling semi-logarithmically with cycles per burst; microbubble infusion improved consistency but not mean T1 enhancement, and reducing burst PRF significantly decreased enhancement.
Duration of biological effect 3 μs
Safety-related matter No safety benefit was observed for 1-pulse bursts compared with bursts containing more cycles, and no adverse effects were reported.

Brain Region

Visualization unavailable

Ultrasound Parameters

Ultrasound instrument None.
FUS Frequency 1.18 MHz
FUS Mode pulsed
Pulse duration 3e-6 s
Duration of a single FUS session 10 ms
Treatment frequency single

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search